Home
Learn about CAF
Read current news
Learn about HIV/AIDS
See current statistics
Browse CAF resources
Read recommended links
Visit the CAF Store
Send CAF your comments or questions
Click to make a secure online donation to CAF

Children's AIDS Fund
P.O. Box 16433
Washington DC 20041

Toll-free:
(866) 829-1560
(800) 557-8529 FAX

News & Views:HIV in the News
 
The HIV Update read other HIV Updates
see HIV/AIDS statistics

Volume 4, Number 32
June 26, 2003

In this edition:


UN AIDS Report Estimates Condom HIV Failure Rate at 10 Percent

A draft report for the United Nation’s AIDS agency has found that even when people use condoms consistently, the failure rate for protection against HIV is an estimated 10 percent, making them a larger risk than portrayed by many advocate groups.

The report, which looked at two decades of scientific literature on condoms, is likely to add fuel to a heated political battle on U.S. policy in fighting AIDS in the developing world.

The debate pits proponents of abstinence, who say that the Bush administration should abandon or sharply reduce condom promotion, against health specialists, who say that condoms play an integral part in preventing the spread of AIDS. The disease has killed more than 20 million people worldwide and now infects 42 million.

In previous reports, condom effectiveness against HIV has been widely estimated at between 46 percent and 100 percent. Many advocates of condoms have said they provide nearly 100 percent protection when used correctly. UNAIDS has voiced hope that the report, which was viewed by the Boston Globe, not only clears up confusion over condom effectiveness but also helps educate people in the United States and worldwide about how to use condoms properly.

The conclusions do not mean that every tenth condom is defective, but rather that something has gone wrong in about 10 percent of their use. In many cases, specialists said, human error is the source of the failure, resulting in condoms slipping off, breaking, or not being put on early enough.

The report is under review by UNAIDS, and a final version will not be released until the end of the month. The organization's top science adviser said the 10 percent failure estimate was “reasonable.”

The leading author on the report, Norman Hearst, a professor at the University of California at San Francisco, “makes a cogent argument that we should be talking about safer sex, not safe sex, with condoms,” said Catherine A. Hankins, a chief scientific adviser to UNAIDS.

The report also said that the failure rate to protect against HIV was probably the same in preventing pregnancies.

Edward C. Green, a senior research scientist at the Harvard School of Public Health, said that the data on condom effectiveness should help set policy and that people in developing countries should know about that risk. One chance in 10 of condom failure is “not good enough for a fatal disease,” Green said. “The way condoms are marketed in Africa and other developing parts of the world is as if they were 100 percent safe. Condoms have brand names like Shield and Protector that gives the impression that they are 100 percent safe.”

Shepherd Smith, president of the Institute for Youth Development, a group that advocates abstinence, also said the draft report and other reports should lead to an evaluation of HIV-prevention efforts. “We took an idea that was unproven in the '80s, said this was what's going to work in this epidemic, and clearly it hasn't,” he said. “The data doesn't support it.”

Condom promoters have long said that condoms can provide almost complete protection against HIV. For instance, a September 2002 report, “Condoms Count,” published by Population Action International, a Washington-based policy advocacy group, said, “Public health experts around the globe agree that condoms block contact with bodily fluids that can carry the HIV virus and have nearly 100 percent effectiveness when used correctly and consistently.”

One of its cited sources was a 2001 National Institutes of Health report. The report, which involved four government agencies, 28 condom specialists, and a review of 138 scientific papers, found that “consistent condom use decreased the risk of HIV/AIDS transmission by approximately 85 percent.”

The National Institutes of Health and draft UNAIDS reports cited inherent difficulties in coming to such an estimate. Health analysts said the only way to arrive at such a figure is to examine a combination of data: interviews with sexually active heterosexual couples; self-reported data on condom use; and long-term HIV testing of uninfected people. Nada Chaya, a senior research associate at Population Action International and the lead author of “Condoms Count,” said of the “nearly 100 percent effectiveness” claim, “technically we are right, if condoms are used correctly and consistently.”

She said her group and others “should carry more responsibility” in telling people that condoms do not completely protect against HIV. “There is no safe sex,” she said. “Safer sex? Yes.”

Terri Bartlett, the group's vice president for public policy, expressed concern that proponents of abstinence alone would use the 10 percent failure estimate to reduce condom availability. This, she said, would lead to more people becoming infected with the deadly virus. The review over condom effectiveness closely follows Congress's passage of President Bush's $15 billion plan to fight AIDS during the next five years. The president repeatedly has said that nations should follow the example of Uganda, which engineered a dramatic reversal of HIV infection rates in the 1990s through strong political leadership and the ABC program, which stands for abstinence, being faithful to one partner, and, if that fails, use of condoms.

Abstinence advocates, which include many faith-based groups, seized on the Uganda example, cited relatively low condom use there, and won a provision in the legislation that said one-third of the AIDS prevention money must be used in abstinence programs by the third year of the five-year plan.

Green, the Harvard research scientist, and many public health specialists said that a comprehensive approach must be used to fight AIDS and that the most important part of the ABC approach probably is B -- being faithful to one partner.

“If we tell youth that if you use condoms, you will be safe, then we are actually fueling the epidemic,” said Vinand M. Nantulya, senior health adviser at the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Nantulya, formerly a key adviser to President Yoweri Museveni of Uganda, said the key lesson from Uganda was “that it wasn't a choice between abstinence or condoms, but that it was everything. In Uganda, we promoted condoms in the context of if you stray, use a condom.”

Hankins, the UNAIDS adviser, also argued for a combination of approaches to fight AIDS and said that each country, and areas inside countries, require tailored responses to the epidemic. She said condoms had a role everywhere. The key now, she said, was to teach correct ways to use them.

The most frequent errors: men don't leave enough space at the end of the condom to collect the sperm; not using lubrication, which reduces the risk of the condom breaking; and not putting on a condom prior to genital contact.

“We need a combination of prevention, postponing sexual activities, reducing partners, and using condoms,” Hankins said.

[Boston Globe on 6/22/03]


HIV Increasing Among Adolescents and Young Adults in Massachusetts

The incidence of HIV and AIDS among teens and young adults in Massachusetts has risen significantly over the past four years, accounting for 301 of the new cases reported during that span, according to new statistics from the state Department of Public Health.

Since the state started its HIV surveillance in 1999, the number of reported cases among 13- to 24-year-olds has risen from 6.1 percent to 8.7 percent. The statistics show that 77 percent of the cases were diagnosed in 19- to 24-year-olds, although infection can happen much earlier than diagnosis.

Intravenous drug use was the cause of 10 percent of the new cases among adolescents and young adults.

“These new statistics are alarming,” Public Health Commissioner Christine Ferguson said in a statement.

Cities with the highest percentage of HIV and AIDS diagnoses within younger age groups were Chelsea, Medford, Lawrence, Chicopee, Brookline, Somerville, Holyoke, Everett, Brockton and Revere.

Over the past four years, the number of new HIV and AIDS cases among those over 50 has also increased, accounting for 12 percent of the reported cases in 2002, compared to 9.2 percent in 1999.

According to the most recent report from the Pediatric Spectrum of Disease Study, no infants in Massachusetts contracted HIV from their mothers during 2001-- the first time that has been achieved since the project began monitoring perinatal transmissions.

Since 1999, a total of 4,219 HIV and AIDS cases have been reported in Massachusetts. Since the onset of the disease in the mid-1980s, 17,998 residents have been diagnosed with AIDS. Sixty percent have died. There are currently about 19,000 to 21,000 living with HIV/AIDS. According to public health officials, about one-quarter of them do not know their HIV status.

[Associated Press, 6/24/03]


Study Finds High HIV Incidence and Risk Taking By Gay Men in South Beach; More Effective Interventions Needed

Recent studies have reported high rates of sexual risk-taking and HIV infection among young men who have sex with men (MSM).

In 1996, Miami-Dade County, Florida, had one of the highest AIDS rates among U.S. metropolitan areas. South Beach, situated at the southern end of Miami Beach, was among the top three ZIP-code areas for Miami-Dade County in the number of reported AIDS cases.

A new study published in the Journal of Acquired Immune Deficiency Syndromes has found that a high prevalence of “unprotected” sex, drub abuse and HIV infection among MSM in South Beach.

All 100 men who completed the study interview and questionnaire provided a specimen for OraSure HIV testing, and 93 percent reported a prior HIV test. Fifteen percent tested positive for HIV antibodies. The researchers estimated the incidence South Beach’s HIV incidence to be 6.3 percent.

Recent migrants to South Beach were more likely to test HIV positive than were longer-term residents. There was a trend for MSM who did not have a primary partner to be more likely to test HIV positive. Orasure test positivity was associated with higher reported number of anal intercourse partners and "cruising" in public areas for sex partners in the prior year. Neither age nor race/ethnicity was associated with HIV antibody status.

Of those surveyed in this study, approximately one half reported using ecstasy (MDMA; 51 percent), or cocaine (48 percent) within the previous year. Forty-five percent had used three or more “recreational” drugs within the past year; 34 percent reported at least weekly use of some drug. More than half (56 percent) reported having had anal sex while high on alcohol and/or drugs during the previous year; 24 percent reported that at least one half of their anal sex was under the influence of alcohol and/or drugs.

Within the past year, 81 percent of respondents reported anal intercourse; 45 percent of the sample reported engaging in “unprotected” anal intercourse (UAI). UAI was not associated with age, race, educational background or length of residency. MSM having a primary partner were significantly more likely to report engaging in UAI in the last year than were MSM not having a primary partner. Men "cruising" in public places were significantly less likely to report UAI than were those who did not report "cruising."

MSM who reported engaging in “unprotected” receptive oral intercourse with ejaculation tended to report engaging in UAI. Having a primary partner, "cruising," and fellatio with ejaculation were significant predictors of UAI in the past year in the logistic regression model.

"The high prevalence of UAI and HIV infection in South Beach attest to a previously undocumented public health concern," the study authors concluded. "The extremely high estimated incidence for young MSM in South Beach highlights the urgent need for more effective risk-reduction interventions and further epidemiological research on resort areas."

Of the 100 MSM interviewed, 48 identified as white, 44 as "Hispanic, Latino, Spanish heritage" five as African American, and three as "other." Median age was 28 years. Forty-one (41 percent) reported a current relationship with a primary partner. By self-identification, 84 percent identified as gay or homosexual; 12 percent as bisexual; and 4 percent as heterosexual.

[Journal of Acquired Immune Deficiency Syndromes, 6/1/03]


Enjoyment of “Unprotected” Sex, Drug Abuse and Poor Communication All Triggers for Risky Sex Among Gay Men

Two behaviors that proved the most likely predictors of risky sexual behavior among gay men— drug abuse and enjoyment of “unprotected” receptive anal sex-- accounted for risky sex in one-third of the men in a recent study, according to Margaret A. Chesney, PhD, who conducted the study while at the University of California, San Francisco.

Gay men who have poor communication skills and feel unable to protect themselves against HIV are more likely to engage in risky sexual behaviors, according to the newly released data.

The research, published in the June 2003 issue of the American Journal of Public Health, concludes that these are among many different combinations of behavioral factors that may be linked to risky sex among gay men.

The data reported by Chesney and colleagues come from a study, still in progress, called EXPLORE, the first randomized clinical trial examining whether behavioral counseling might help reduce the rates of HIV infection in the United States.

The men enrolled in the study are at "high risk" of HIV infection, according to Beryl Koblin, PhD, of the New York Blood Center and colleagues. Koblin and colleagues reported that alcohol and drug use, multiple partners or one primary partner are all associated with “unprotected” sex among the men

The results of the trial will be available in 2004. The study was supported by the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health and the National Institute on Alcohol Abuse and Alcoholism.

[Medical Letter on the CDC & FDA, 6/22/03]


Oklahoma Man Sentenced to Prison for Exposing Others to HIV

An HIV-infected man who police said sought out mentally retarded individuals to satisfy his sexual appetite received prison time Wednesday for sexually assaulting two men. Luis Jimenez showed no emotion as Garfield County District Judge Ronald Franklin pronounced sentence of 10 years for first-degree rape and forcible oral sodomy and five years for exposing others to the AIDS virus.

Besides his prison terms, which will run concurrently, Jimenez will pay nearly $2,500 in medical costs incurred since he was arrested in December.

Jimenez was suspended from his position as a physical therapy technician at St. Mary's Regional Medical Center after his arrest. Hospital officials said they had no knowledge of his alleged activities or health status.

Jimenez's job at the hospital allowed him access to one of his victims, according to court documents. He went to a man's house November 16 under the guise of checking up on the patient's stomach ailment, according to an affidavit filed in Garfield County District Court. Jimenez told the man, who relies on his sister to care for him, he needed to come to his house for a more thorough checkup, the affidavit states. Jimenez then forced the man to have sex with him. He admitted to having sex with the man when interviewed November 20 by Enid police, according to the affidavit. He also was accused of forcibly sodomizing another man in October 2000 after the man had raked some leaves at his house.

[Associated Press, 6/25/03]


Rapid HIV Test is Centerpiece of New Prevention Effort

A new, rapid HIV test is the centerpiece of a major effort, starting Friday, to bring people who don't know they're infected with the AIDS virus out of the shadows and into a doctor's care.

The Centers for Disease Control and Prevention plans to buy nearly 250,000 rapid tests for $2 million and distribute them to state health departments as part of a major HIV-prevention initiative, according to the test's manufacturer. The announcement is one of a flurry of activities planned by AIDS advocacy groups, AIDS service providers and their corporate partners to underscore the importance of testing on Friday, National HIV Testing Day.

"It's tragic that more than two decades into the disease, we still have 250,000 people who don't know they have it," CDC Director Julie Gerberding said Wednesday. "Our goal is to help people to know their status and get treated."

Taken together, these programs also mark a major new trend in AIDS prevention. With a $35 million push from CDC-- through its initiative called "Advancing HIV Prevention: New Strategies for a Changing Epidemic"-- HIV tests are rapidly becoming a critical component of prevention efforts, along with traditional programs designed to teach people most at risk to protect themselves.

"Knowing one's HIV status is one of the most powerful motivators of behavior change," Gerberding said. "Most people who know they're HIV-positive take appropriate steps to protect their partners."

By vastly expanding access to the newly approved test, which is made by Orasure Technologies, the CDC hopes to reduce the number of people who have HIV and don't know it. Of an estimated 900,000 HIV-positive people in the USA, about 30 percent either have not been tested or never returned for their test results. Many won't find out they're infected, or seek treatment, until it's too late. CDC hopes to shrink that population to just 5 percent of those who are infected.

"The most important aspect of this new, rapid test is that each year 10,000 people in the U.S. test positive but never return for their test results," says Mick Ellis, director of testing and counseling for the Whitman-Walker Clinic in Washington, D.C. "With the rapid test, we'll be able to give them their results in 20 minutes."

[USA Today, 6/26/03]


HIV Cases Increase in Galveston County, Texas

Though Galveston County, Texas, has an HIV infection rate lower than the state average, the number of new HIV cases in the county increased last year. In 2002, 41 new cases of HIV infection were reported in Galveston County, up from 19 new cases reported in 2001. Thirty-six cases were reported in 2000. State law requires positive HIV tests at health care facilities to be reported to the Texas Department of Health.

While the increase appears to be significant, Dr. Sharon Melville at the Texas Department of Health speculated that cases from 2001 perhaps were not reported to the state until the next year. "It's probably a little blip in how the reports were processed. That wouldn't get me very concerned," said Melville.

Although numbers for the beginning of 2003 have not been released, Melville said the county's rates have traditionally been slightly lower than the state average. Statewide, the rate of new HIV infection is 22 per 100,000 people in 2002, but it is 16.1 per 100,000 in Galveston County. "There's not as many cases in Galveston County," said Melville. "That doesn't mean it's not active in Galveston County. It just means that infection numbers aren't quite as high."

The number of HIV cases, however, is distressing to Melville, particularly "because of all the emphasis on prevention activity." "We're still seeing new cases," she said. Melville added that several different groups, most notably African Americans and homosexual men, are more likely to become infected.

[Houston Chronicle, 6/19/03]


FDA Approves First Once-daily Protease Inhibitor for AIDS

The government has approved the first once-a-day protease inhibitor to treat HIV infection. Protease inhibitors are a powerful type of drug that revolutionized HIV care in the mid-1990s. While they're not a cure, protease inhibitors taken together with older AIDS medicines suppress HIV enough to allow many patients to stay far healthier for years longer. But these so-called “drug cocktails” require swallowing handfuls of pills several times a day.

The newest protease inhibitor, Reyataz, requires just a once-daily dose of two pills, taken with food-- plus whatever older medications patients take as part of their daily cocktail.

Six other protease inhibitors already are sold, but require taking several pills two or three times a day.

The Food and Drug Administration approved use of Reyataz as part of combination HIV therapy on Friday. Manufacturer Bristol-Myers Squibb said the drug, known chemically as atazanavir, would hit pharmacy shelves next month. The company refused to reveal the price, saying only that it would be competitive with other protease inhibitors.

Reyataz appears to work as well as other protease inhibitors. But a common side effect of other protease inhibitors is a rise in cholesterol-- and for some reason, Reyataz so far doesn't appear to cause that problem, the FDA said.

However, up to 24 percent of Reyataz patients can experience jaundice, a yellowing of the skin or eyes. It seems to quit when patients stop taking the drug, and doesn't appear to be associated with liver injury, the FDA said. Other side effects include nausea, infection, headache and diarrhea.

[Associated Press, 6/20/03]


FDA Commissioner Aims for Faster Drug Reviews

The nation's top drug regulator said on Monday he aims to cut the time it takes to bring new medicines to the public, while still ensuring that any negative side effects are promptly reported to the government. Speaking at the annual meeting of the Biotechnology Industry Organization in Washington, U.S. Food and Drug Administration (FDA) commissioner Mark McClellan said the agency will soon announce new initiatives to reduce the cost of drug development by cutting the time the agency spends reviewing applications.

The agency will also work closely with drug developers to ensure that new drug applications are properly organized from the first time they are submitted, he said. That would avoid time-consuming and costly setbacks such as the 2001 rejection of ImClone System Inc.'s application to market its experimental cancer drug Erbitux because the agency was unhappy with how the trials were conducted and the data were organized. After the FDA's refusal, shares of ImClone sharply declined, setting in motion an insider trading scandal and delaying potential approval of Erbitux by at least two years.

Since taking the job in 2002, McClellan has repeatedly made clear he intends to speed the drug review process. Over the past six months, some half-dozen new drugs have been approved, some unexpectedly, helping lift the American Stock Exchange Biotechnology Index of biotech stocks more than 50 percent since March. McClellan said he thinks the gain in the sector is justified.

He noted, however, that while the FDA is "working hard" to reduce the cost of drug development, biotechnology companies must do their part to cut development time by devising new research techniques. Reduced time for development, he said, makes it more critical than ever that companies promptly report any problems that arise from the use of new medicines.

"The FDA has always relied on a voluntary reporting system for adverse events," he said. "The truth is there are countless adverse events that go unreported."

He said he plans to institute systems to ensure that adverse side effects are reported in a timely way. For instance, McClellan said the FDA plans to introduce a real-time electronic monitoring system that will help alert the agency of potential risks with newly approved drugs.

Many drugs are approved on the condition that companies conduct further clinical trials to monitor the drug's performance in a wider population. Few companies actually conduct such trials. "If we have this information, we can have more confidence that potential problems will be identified," said McClellan.

[Reuters Health, 6/24/03]


West Palm Beach AIDS Housing Program Under Investigation

Some managers of the Haitian American Community Council are being investigated for steering AIDS clients toward landlords with ties to the agency's employees, West Palm Beach City Administrator Ed Mitchell said Tuesday. West Palm Beach launched the inquiry last week following complaints an unspecified number of managers may have had conflicts of interest in placing clients in homes owned by the organization's employees or their business acquaintances, Mitchell said. The city oversees more than $300,000 a year in federal money given to the council to provide housing for AIDS clients.

"The matters that came to the city's attention are being investigated as to whether there was a conflict of interest," said Samuel Thomas, a city attorney. Mitchell declined to name the managers or the properties under investigation.

West Palm Beach is the third of the council's four government financial backers investigating conflict-of-interest issues with management of the Delray Beach-based organization.

The Palm Beach County Department of Community Services and the Children's Services Council of Palm Beach County have raised concerns in the past two weeks that the organization's director, Daniella Henry, and former supervisor, Gethro Louis Jean, bought a house together in West Palm Beach while they were co-workers. Louis Jean also has operated an immigration, personal-injury and translation service company, Legacy Service Center, using the Haitian council's Lantana address while he was working for the organization, according to state records and Louis Jean's business card.

The two agencies placed the council under closer supervision and required Henry and the five board members to affirm the organization's conflict-of-interest policies. They also will need to resolve other administrative problems, such as poor record keeping, that were pinpointed by the agencies. The county and CSC together give the Haitian group nearly $300,000 to provide clients with immigration assistance and social services.

Haitian council board member Barry Silver said he didn't know anything about West Palm Beach's investigation and couldn't comment. Neither Henry nor board President Carolyn Zimmerman could be reached.

Mitchell said the city's attorneys and finance and economic-development officials are investigating the council's allegations with support from the U.S. Department of Housing and Urban Development, which gives the AIDS housing money to the city and oversees it. West Palm Beach disburses the federal money to other agencies providing housing for AIDS clients.

Mitchell didn't immediately know how many AIDS clients are served by the Haitian council's program. The city also hasn't yet released the names of the landlords affiliated with the program.

The federal money overseen by the agency pays for all or part of the clients' rental payments. The payments are supposed to be paid to the landlord.

Mitchell said he wasn't sure when the inquiry will be completed. "We are doing our background work to determine what happened with our funds," Mitchell said.

If the city finds severe problems, it may consider dropping the council and selecting another agency to oversee the money, city officials said.

[Sun-Sentinel (Fort Lauderdale, FL), 6/25/03]


The HIV Update is a weekly report of articles, studies and other information related to HIV/AIDS, sexually transmitted diseases and related risk behaviors compiled from various news sources by the Children’s AIDS Fund.

The Children’s AIDS Fund is a non-profit, non-partisan organization dedicated to helping limit the suffering of HIV-impacted children through direct assistance and resources, as well as through technical assistance for their parents and care-givers. For additional information, call (703) 471-7350.

Previous editions of the HIV Update are available on-line at http://www.childrensaidsfund.org/news.asp.

 

   Children's AIDS FundP.O. Box 16433 Washington D.C. 20041